Symbol
Altimmune, Inc.
Full name of the company.
MEDICAL-DRUGS
Industry name
DRUGS
Major industry name
Medical
Sector name
$4.24
Current price of the stock
$3M
Trading volume of the stock
$301.4M
Market capitalization of the company
Small Cap
Category of market capitalization
-
Long-term growth mean estimate
4.60
Mean analyst rating
427.71%
Potential price appreciation based on analyst price targets
-
Percentage difference of EPS surprise
-
Dividend change over 1 year
$0.00
Shows the amount of dividend paid
-
Total debt to total equity ratio
16.87
Current ratio
100.00%
Gross profit margin
-495340.00%
Operating profit margin
-495340.00%
Earnings before interest and taxes (EBIT) margin
-
Earnings before interest, taxes, depreciation, and amortization (EBITDA) margin
-456900.00%
Pretax profit margin
-456900.00%
Net profit margin
-17.13%
Measures profitability relative to shareholders' equity
-17.13%
ROE excluding intangible assets
-15.45%
Measures profitability relative to total assets
-17.13%
Measures profitability relative to invested capital
0.00
Asset turnover ratio
-
Inventory turnover ratio
0.00
Receivables turnover ratio
-
Average number of days it takes to collect receivables
-2.72
Measures valuation relative to earnings
-
P/E based on future earnings estimates
5796.16
Measures valuation relative to sales
2.26
Measures valuation relative to book value
-1.41
Measures valuation relative to operating cash flow
-1.41
Measures valuation relative to free cash flow
0
Indicates company's M&A activity
© 2022 - 2025 QuantStrategy.io, Arizet Labs, LLC
